Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Survival in oncology reimbursement decision-making | CMAR
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma - Digestive and Liver Disease
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
ROC analysis of the pretreatment AAPR by setting overall survival as... | Download Scientific Diagram
Merck Announces KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Overall Survival (OS) in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib | Business Wire
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia | Leukemia
Surrogate Endpoint | Definitive Healthcare
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation | Scientific Reports
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
図10 Overall survival (primary endpoint)
Cumulative overall survival (OS) and progression-free survival (PFS)... | Download Scientific Diagram
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis - The Lancet Oncology
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials | BMC Cancer | Full Text
Clinical Trial Design - Endpoints - Quantics Biostatistics
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
